Coordinating CAR-T trials means managing tight timelines, cryogenic handling, staffing gaps, and chain-of-identity risks where even small missteps can delay care.
- Digital Isn't The Strategy: What Actually Drives Value In Clinical Supply Transformation
- Why Lean Clinical Teams Often Create Fragile Clinical Supply Chains
- The Clinical Supply Risk In Pharma's PE Boom
- Choosing The Right Logistics Team For Complex Clinical Trials
- Scaling Security And Speed In Last-Mile Cold Chain Delivery For Clinical Trials
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
- Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders, Part 2
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
A Supply Chain Management Solution Designed for Clinical Research
In this use case, follow along the clinical supplies management journey to learn how GxP Inventory replaces fragmented, spreadsheet-based processes to optimize visibility, traceability, and compliance.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
Automation Testing In RTSM Software: What Is It And What's The Impact
Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Biosample Tracking: A Consenting Dilemma
Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.
-
Delivering Lifesaving Intravenous Therapy Across The USA Within 24 Hours
The goal was to successfully deliver time-critical intravenous therapy, Legalon, from a GMP Philadelphia depot to sites across the USA to treat patients suffering from amatoxin poisoning.
-
The Dual Sourcing Approach
Having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting
Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.
-
Investigational Medicinal Products: Labeling Changes And Their Implications
Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
Clinical Development And Supply: Breaking Down Early Small Molecule Development
Adopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.